SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-320126
Filing Date
2018-11-07
Accepted
2018-11-07 07:19:35
Documents
2
Period of Report
2018-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d604052d8k.htm 8-K 15362
2 EX-99.1 d604052dex991.htm EX-99.1 80284
  Complete submission text file 0001193125-18-320126.txt   96791
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35409 | Film No.: 181164703
SIC: 2834 Pharmaceutical Preparations